rs199505182
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_015512.5(DNAH1):c.933C>T(p.Asp311Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00528 in 1,609,148 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0040 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 28 hom. )
Consequence
DNAH1
NM_015512.5 synonymous
NM_015512.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.470
Publications
2 publications found
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
- spermatogenic failure 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- ciliary dyskinesia, primary, 37Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic male infertility due to sperm motility disorderInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 3-52331209-C-T is Benign according to our data. Variant chr3-52331209-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 478510.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.47 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00396 (603/152264) while in subpopulation AMR AF = 0.00667 (102/15302). AF 95% confidence interval is 0.00562. There are 2 homozygotes in GnomAd4. There are 276 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAH1 | NM_015512.5 | c.933C>T | p.Asp311Asp | synonymous_variant | Exon 7 of 78 | ENST00000420323.7 | NP_056327.4 | |
| DNAH1 | XM_017006129.2 | c.933C>T | p.Asp311Asp | synonymous_variant | Exon 8 of 80 | XP_016861618.1 | ||
| DNAH1 | XM_017006130.2 | c.933C>T | p.Asp311Asp | synonymous_variant | Exon 8 of 79 | XP_016861619.1 | ||
| DNAH1 | XM_017006131.2 | c.933C>T | p.Asp311Asp | synonymous_variant | Exon 8 of 79 | XP_016861620.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH1 | ENST00000420323.7 | c.933C>T | p.Asp311Asp | synonymous_variant | Exon 7 of 78 | 1 | NM_015512.5 | ENSP00000401514.2 | ||
| DNAH1 | ENST00000486752.5 | n.1194C>T | non_coding_transcript_exon_variant | Exon 7 of 77 | 2 | |||||
| DNAH1 | ENST00000497875.1 | n.1098C>T | non_coding_transcript_exon_variant | Exon 8 of 21 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00396 AC: 603AN: 152146Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
603
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00343 AC: 823AN: 239722 AF XY: 0.00345 show subpopulations
GnomAD2 exomes
AF:
AC:
823
AN:
239722
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00541 AC: 7886AN: 1456884Hom.: 28 Cov.: 31 AF XY: 0.00533 AC XY: 3857AN XY: 724086 show subpopulations
GnomAD4 exome
AF:
AC:
7886
AN:
1456884
Hom.:
Cov.:
31
AF XY:
AC XY:
3857
AN XY:
724086
show subpopulations
African (AFR)
AF:
AC:
23
AN:
33420
American (AMR)
AF:
AC:
176
AN:
43978
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
25994
East Asian (EAS)
AF:
AC:
5
AN:
39600
South Asian (SAS)
AF:
AC:
47
AN:
84976
European-Finnish (FIN)
AF:
AC:
37
AN:
53138
Middle Eastern (MID)
AF:
AC:
9
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
7278
AN:
1109796
Other (OTH)
AF:
AC:
308
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
430
859
1289
1718
2148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00396 AC: 603AN: 152264Hom.: 2 Cov.: 32 AF XY: 0.00371 AC XY: 276AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
603
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
276
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
46
AN:
41538
American (AMR)
AF:
AC:
102
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5174
South Asian (SAS)
AF:
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
AC:
3
AN:
10612
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
415
AN:
68022
Other (OTH)
AF:
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 28, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
DNAH1: BP4, BP7, BS2 -
Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.